Swiss (SMI) Life Sciences Industry Analysis

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Fri, 26 Jul 2024	CHF 57.6b	CHF 10.3b	CHF 1.0b	45.5x	57.4x	5.6x
Sun, 23 Jun 2024	CHF 51.3b	CHF 10.3b	CHF 1.0b	44.2x	51.1x	5x
Tue, 21 May 2024	CHF 56.1b	CHF 10.3b	CHF 1.0b	46x	56x	5.5x
Thu, 18 Apr 2024	CHF 54.6b	CHF 10.3b	CHF 1.0b	43.6x	54.5x	5.3x
Sat, 16 Mar 2024	CHF 52.8b	CHF 10.2b	CHF 1.0b	44.7x	52.6x	5.2x
Mon, 12 Feb 2024	CHF 48.1b	CHF 10.2b	CHF 1.0b	42.5x	47.2x	4.7x
Wed, 10 Jan 2024	CHF 41.4b	CHF 9.8b	CHF 1.5b	31.4x	27.7x	4.2x
Fri, 08 Dec 2023	CHF 39.2b	CHF 9.8b	CHF 1.5b	29.5x	26.2x	4x
Sun, 05 Nov 2023	CHF 38.8b	CHF 9.8b	CHF 1.5b	27.3x	26x	4x
Tue, 03 Oct 2023	CHF 46.5b	CHF 9.8b	CHF 1.5b	31.7x	31.2x	4.8x
Thu, 31 Aug 2023	CHF 52.7b	CHF 9.8b	CHF 1.5b	36.6x	35.4x	5.4x
Sat, 29 Jul 2023	CHF 53.8b	CHF 9.8b	CHF 1.5b	36.8x	34.8x	5.5x
Mon, 26 Jun 2023	CHF 55.2b	CHF 9.7b	CHF 1.6b	34.3x	33.7x	5.7x
Wed, 24 May 2023	CHF 61.1b	CHF 9.7b	CHF 1.6b	39.2x	37.4x	6.3x
Fri, 21 Apr 2023	CHF 59.9b	CHF 9.7b	CHF 1.7b	41.3x	35.9x	6.2x
Sun, 19 Mar 2023	CHF 56.3b	CHF 9.7b	CHF 1.7b	40.8x	34x	5.8x
Tue, 14 Feb 2023	CHF 57.4b	CHF 9.6b	CHF 1.6b	33.3x	35.1x	6x
Thu, 12 Jan 2023	CHF 52.8b	CHF 9.2b	CHF 1.3b	39.3x	39.8x	5.8x
Sat, 10 Dec 2022	CHF 50.5b	CHF 9.2b	CHF 1.3b	37.3x	38x	5.5x
Mon, 07 Nov 2022	CHF 50.4b	CHF 9.2b	CHF 1.3b	39.1x	37.9x	5.5x
Wed, 05 Oct 2022	CHF 52.6b	CHF 9.2b	CHF 1.3b	41.7x	40.7x	5.7x
Fri, 02 Sep 2022	CHF 52.9b	CHF 9.2b	CHF 1.3b	41.6x	40.9x	5.8x
Sun, 31 Jul 2022	CHF 57.5b	CHF 8.9b	CHF 1.3b	35.2x	43.9x	6.5x
Tue, 28 Jun 2022	CHF 53.5b	CHF 8.5b	CHF 1.1b	47.2x	49.6x	6.3x
Thu, 26 May 2022	CHF 55.9b	CHF 8.5b	CHF 1.1b	45.1x	51.8x	6.6x
Sat, 23 Apr 2022	CHF 64.4b	CHF 8.5b	CHF 1.1b	58.5x	59.7x	7.6x
Mon, 21 Mar 2022	CHF 68.8b	CHF 8.2b	CHF 1.1b	52.8x	64.7x	8.4x
Wed, 16 Feb 2022	CHF 65.8b	CHF 8.0b	CHF 1.1b	53.9x	61.6x	8.2x
Fri, 14 Jan 2022	CHF 71.9b	CHF 7.4b	CHF 929.4m	74.8x	77.3x	9.7x
Sun, 12 Dec 2021	CHF 79.9b	CHF 7.4b	CHF 918.2m	84.5x	87x	10.9x
Tue, 09 Nov 2021	CHF 78.4b	CHF 7.4b	CHF 919.0m	81.8x	85.4x	10.7x
Thu, 07 Oct 2021	CHF 76.7b	CHF 7.4b	CHF 919.6m	77.1x	83.4x	10.4x
Sat, 04 Sep 2021	CHF 82.1b	CHF 7.4b	CHF 920.8m	86.4x	89.1x	11.1x
Mon, 02 Aug 2021	CHF 75.2b	CHF 7.4b	CHF 920.8m	62.2x	81.7x	10.2x

Current Industry PE

Investors are optimistic on the Swiss Life Sciences industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 57.4x which is higher than its 3-year average PE of 50.0x.

The 3-year average PS ratio of 6.6x is higher than the industry's current PS ratio of 5.6x.

Past Earnings Growth

The earnings for companies in the Life Sciences industry have grown 2.9% per year over the last three years.
Revenues for these companies have grown 12% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?


CH Market	-1.02%
Healthcare	0.96%
Life Sciences	4.39%
Clinical Research and Equipment	4.39%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Company	Last Price	7D	1Y	Valuation
LONN Lonza Group	CHF 522.60	1.0% +CHF 361.1m	4.2%	PE57.7x
BANB Bachem Holding	CHF 86.65	2.3% +CHF 146.2m	8.6%	PE58.1x
SFZN Siegfried Holding	CHF 1.01k	1.2% +CHF 51.5m	29.3%	PE38.3x

Company

Last Price

Valuation

LONN Lonza Group

CHF 522.60

1.0%
+CHF 361.1m

4.2%

PE57.7x

BANB Bachem Holding

CHF 86.65

2.3%
+CHF 146.2m

8.6%